Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409 · see citing works

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384 · see citing works

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969 · see citing works

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1× · see citing works

Alzheimer’s disease

Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134 · see citing works

Purification and cloning of amyloid precursor protein β-secretase from human brain

Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612 · see citing works

Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438 · see citing works

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080 · see citing works

Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis

Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · see citing works

Axonal Neuregulin-1 Regulates Myelin Sheath Thickness

Michailov, G. V., Sereda, M. W., Brinkmann, B. G., Fischer, T. M., Haug, B., Birchmeier, C., Role, L. W., Lai, C., Schwab, M. H., & Nave, K. (2004) · Science · doi:10.1126/science.1095862 · Cited by 940 · see citing works

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: Implications for Alzheimer’s disease therapeutics

Roberds, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1317 · Cited by 705 · see citing works

Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703 · see citing works

Bace1 modulates myelination in the central and peripheral nervous system

Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006) · Nature Neuroscience · doi:10.1038/nn1797 · Cited by 608 · see citing works

The Alzheimer's disease Beta-secretase enzyme, BACE1

Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550 · see citing works

BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions

Laird, F. M., Cai, H., Savonenko, A. V., Farah, M. H., He, K., Melnikova, T., Wen, H., Chiang, H.-C., Xu, G., Koliatsos, V. E., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2766-05.2005 · Cited by 521 · see citing works

Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation

Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608856200 · Cited by 436 · see citing works

Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology

Olsson, A., Vanderstichele, H., Andreasen, N., Meyer, G. D., Wallin, A., Holmberg, B., Rosengren, L., Vanmechelen, E., & Blennow, K. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.039347 · Cited by 424 · see citing works

Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ

Sastre, M., Dewachter, I., Rossner, S., Bogdanovic, N., Rosen, E., Borghgraef, P., Evert, B. O., Dumitrescu-Ozimek, L., Thal, D. R., Landreth, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503839103 · Cited by 373 · see citing works

Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein

Tamagno, E., Guglielmotto, M., Aragno, M., Borghi, R., Autelli, R., Giliberto, L., Muraca, G., Danni, O., Zhu, X., Smith, M. A., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05072.x · Cited by 338 · see citing works

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

Malmeström, C., Haghighi, S., Rosengren, L., Andersen, O., & Lycke, J. (2003) · Neurology · doi:10.1212/01.wnl.0000098880.19793.b6 · Cited by 318 · see citing works

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

Norgren, N., Sundström, P., Svenningsson, A., Rosengren, L., Stigbrand, T. I., & Gunnarsson, M. (2004) · Neurology · doi:10.1212/01.wnl.0000142988.49341.d1 · Cited by 241 · see citing works

Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease

Roßner, S., Sastre, M., Bourne, K. Z., & Lichtenthaler, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.06.001 · Cited by 196 · see citing works

Type III neuregulin‐1 promotes oligodendrocyte myelination

Taveggia, C., Thaker, P., Petrylak, A., Caporaso, G. L., Toews, A. D., Falls, D. L., Einheber, S., & Salzer, J. L. (2007) · Glia · doi:10.1002/glia.20612 · Cited by 193 · see citing works

Neuregulin 1–erbB Signaling Is Necessary for Normal Myelination and Sensory Function

Chen, S., Velardez, M. O., Warot, X. M., Yu, Z.-X., Miller, S. J., Cros, D. P., & Corfas, G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3785-05.2006 · Cited by 192 · see citing works

Differential regulation of BACE1 promoter activity by nuclear factor‐κB in neurons and glia upon exposure to β‐amyloid peptides

Bourne, K. Z., Ferrari, D. C., Lange‐Dohna, C., Roßner, S., Wood, T. G., & Perez-Polo, J. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21252 · Cited by 188 · see citing works

Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement

Trysberg, E., Nylén, K., Rosengren, L., & Tarkowski, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11279 · Cited by 155 · see citing works

The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage

Owens, T. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000073925.19076.f2 · Cited by 94 · see citing works

Interferon γ stimulates β-secretase expression and sAPPβ production in astrocytes

Hong, H. S., Hwang, E. M., Sim, H. J., Cho, H.-J., Boo, J. H., Oh, S. S., Kim, S. U., & Mook-Jung, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01270-1 · Cited by 81 · see citing works

Aspects of beta-amyloid as a biomarker for Alzheimer's disease.

Andreasson, U., Portelius, E., Andersson, M. E., Blennow, K., & Zetterberg, H. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.59 · Cited by 75 · see citing works

Decrease in age-adjusted cerebrospinal fluid β-secretase activity in Alzheimer's subjects

Wu, G., Sankaranarayanan, S., Tugusheva, K., Kahana, J. A., Seabrook, G. R., Shi, X., King, E., Devanarayan, V., Cook, J. J., & Simon, A. J. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.04.022 · Cited by 49 · see citing works

Cerebrospinal fluid markers in MS patients and their healthy siblings

Haghighi, S., Andersen, O., Odén, A., & Rosengren, L. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00197.x · Cited by 39 · see citing works

Determinants of Cognitive Performance in Systemic Lupus Erythematosus

Breitbach, S. A., Alexander, R. W., Daltroy, L. H., Liang, M. H., Boll, T. J., Karlson, E. W., Partiridge, A. J., Roberts, W. N., Stern, S. H., Wacholtz, M. C., et al. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.2.157.1166 · Cited by 23 · see citing works

Cerebrospinal fluid protein reactions during non-neurological surgery

Anckarsäter, R., Vasić, N., Jidéus, L., Kristiansson, M., Zetterberg, H., Blennow, K., & Anckarsäter, H. S. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00741.x · Cited by 21 · see citing works

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

Palmqvist, S., Schöll, M., Strandberg, O., Mattsson, N., Stomrud, E., Zetterberg, H., Blennow, K., Landau, S., Jagust, W., & Hansson, O. (2017) · Nature Communications · doi:10.1038/s41467-017-01150-x · Cited by 911 · see citing works

Amyloid biomarkers in Alzheimer's disease

Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.002 · Cited by 470 · see citing works

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

Mattsson, N., Insel, P. S., Donohue, M., Landau, S., Jagust, W. J., Shaw, L. M., Trojanowski, J. Q., Zetterberg, H., Blennow, K., & Weiner, M. W. (2015) · Brain · doi:10.1093/brain/awu367 · Cited by 237 · see citing works

Sodium Channel β Subunits: Emerging Targets in Channelopathies

O’Malley, H. A., & Isom, L. L. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071846 · Cited by 236 · see citing works

A novel pathway for amyloid precursor protein processing

Portelius, E., Price, E. A., Brinkmalm, G., Stiteler, M., Olsson, M., Persson, R., Brinkmalm, A., Zetterberg, H., Simon, A. J., & Blennow, K. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.002 · Cited by 169 · see citing works

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

Gisslén, M., Krut, J. J., Andréasson, U., Blennow, K., Cinque, P. M., Brew, B. J., Spudich, S., Hagberg, L., Rosengren, L., Price, R. W., et al. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-63 · Cited by 147 · see citing works

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

Ottervald, J., Franzén, B., Nilsson, K. C., Andersson, L. I., Khademi, M., Eriksson, B., Kjellström, S., Marko‐Varga, G., Végvári, Á., Harris, R. A., et al. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.01.004 · Cited by 141 · see citing works

Amyloid β and APP as biomarkers for Alzheimer’s disease

Zetterberg, H., Blennow, K., & Hanse, E. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.002 · Cited by 113 · see citing works

Voltage-Gated Sodium Channel β Subunits and Their Related Diseases

Bouza, A. A., & Isom, L. L. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_48 · Cited by 111 · see citing works

Cerebrospinal fluid biomarkers of white matter lesions – cross‐sectional results from the LADIS study

Jonsson, M. A. G., Zetterberg, H., van Straaten, E. C. W., LIND, K., Syversen, S., Edman, Å., Blennow, K., Rosengren, L., Pantoni, L., Inzitari, D., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02808.x · Cited by 111 · see citing works

Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment

Parnetti, L., Chiasserini, D., Eusebi, P., Giannandrea, D., Bellomo, G., Carlo, C. D., Padiglioni, C., Mastrocola, S., Lisetti, V., & Calabresi, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111349 · Cited by 109 · see citing works

Disease Biomarkers in Multiple Sclerosis

Harris, V. K., & Sadiq, S. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256329 · Cited by 44 · see citing works

Cognitive and Cortical Plasticity Deficits Correlate with Altered Amyloid-β CSF Levels in Multiple Sclerosis

Mori, F., Rossi, S., Sancesario, G. M., Codecà, C., Mataluni, G., Monteleone, F., Buttari, F., Kusayanagi, H., Castelli, M., Motta, C., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.187 · Cited by 98 · see citing works

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections

Krut, J. J., Zetterberg, H., Blennow, K., Cinque, P. M., Hagberg, L., Price, R. W., Studahl, M., & Gisslén, M. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6688-y · Cited by 91 · see citing works

Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease

Hull, J. M., & Isom, L. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.018 · Cited by 79 · see citing works

Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer’s Disease

Rosén, C., Andréasson, U., Mattsson, N., Marcusson, J. O., Minthon, L., Andreasen, N., Blennow, K., & Zetterberg, H. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8171-4 · Cited by 72 · see citing works

CSF Biomarkers

Mattsson, N., Blennow, K., & Zetterberg, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04944.x · Cited by 68 · see citing works

Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis

Rossi, S., Mancino, R., Bergami, A., Mori, F., Castelli, M., Chiara, V. D., Studer, V., Mataluni, G., Sancesario, G. M., Parisi, V., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511410342 · Cited by 66 · see citing works

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

Mattsson, N., Bremell, D., Anckarsäter, R., Blennow, K., Anckarsäter, H. S., Zetterberg, H., & Hagberg, L. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-51 · Cited by 64 · see citing works

CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?

Stojić-Vukanić, Z., Hadžibegović, S., Nicole, O., Nacka-Aleksić, M., Leštarević, S., & Leposavić, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566225 · Cited by 61 · see citing works

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging

Matías‐Guiu, J. A., Oreja‐Guevara, C., Cabrera‐Martín, M. N., Moreno‐Ramos, T., Carreras, J. L., & Matías‐Guiu, J. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00053 · Cited by 54 · see citing works

Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis

Nisticò, R., Mori, F., Feligioni, M., Nicoletti, F., & Centonze, D. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0162 · Cited by 54 · see citing works

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid

Selnes, P., Blennow, K., Zetterberg, H., Grambaitė, R., Rosengren, L., Johnsen, L., Stenset, V. T. V., & Fladby, T. (2010) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-7-10 · Cited by 52 · see citing works

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

Augutis, K., Axelsson, M., Portelius, E., Brinkmalm, G., Andreasson, U., Gustavsson, M. K., Malmeström, C., Lycke, J., Blennow, K., Zetterberg, H., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512460603 · Cited by 47 · see citing works

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

Pietroboni, A., di Cola, F. S., Scarioni, M., Fenoglio, C., Spanó, B., Arighi, A., Cioffi, S. M. G., Oldoni, E., Riz, M. D. D., Basilico, P., et al. (2017) · Multiple Sclerosis · doi:10.1177/1352458516674566 · Cited by 38 · see citing works

Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway

Portelius, E., Mattsson, N., Pannee, J., Zetterberg, H., Gisslén, M., Vanderstichele, H., Gkanatsiou, E., Crespi, G. A. N., Parker, M. W., Miles, L. A., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0152-5 · Cited by 39 · see citing works

Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

Pietroboni, A. M., Carandini, T., Colombi, A., Mercurio, M., Ghezzi, L., Giulietti, G., Scarioni, M., Arighi, A., Fenoglio, C., Riz, M. A. D., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4182-1 · Cited by 38 · see citing works

CSF β-amyloid predicts prognosis in patients with multiple sclerosis

Pietroboni, A., Caprioli, M., Carandini, T., Scarioni, M., Ghezzi, L., Arighi, A., Cioffi, S. M. G., Cinnante, C., Fenoglio, C., Oldoni, E., et al. (2018) · Multiple Sclerosis · doi:10.1177/1352458518791709 · Cited by 29 · see citing works

Role of amyloid-β CSF levels in cognitive deficit in MS

Gentile, A., Mori, F., Bernardini, S., & Centonze, D. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.035 · Cited by 32 · see citing works

Molecular biomarkers of neurodegeneration

Höglund, K., & Salter, H. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.850033 · Cited by 33 · see citing works

Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis

Dujmović, I. (2011) · Multiple Sclerosis International · doi:10.1155/2011/767083 · Cited by 32 · see citing works

BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants

Timmers, M., Barão, S., Broeck, B. V., Tesseur, I. C., Slemmon, J., Waepenaert, K. D., Bogert, J., Shaw, L. M. J., Engelborghs, S., Moechars, D., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160829 · Cited by 32 · see citing works

Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis

Bassi, M. S., Garofalo, S., Marfia, G. A., Gilio, L., Simonelli, I., Finardi, A., Furlan, R., Sancesario, G. M., Giandomenico, J. D., Storto, M., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00390 · Cited by 29 · see citing works

The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases

Pietroboni, A. M., Colombi, A., Carandini, T., Scarpini, E. A., Galimberti, D., & Bozzali, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200868 · Cited by 30 · see citing works

Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid

Alexopoulos, P., Tsolakidou, A. F., Roselli, F., Arnold, A., Grimmer, T., Westerteicher, C., Leante, M. R., Förstl, H., Livrea, P., Kurz, A., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.009 · Cited by 30 · see citing works

Potential Biomarkers Associated with Multiple Sclerosis Pathology

Mathur, D., Mishra, B. K., Rout, S., Lopez-Iranzo, F. J., López‐Rodas, G., Vallamkondu, J., Kandimalla, R. J. L., & Casanova, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910323 · Cited by 32 · see citing works

The proteomic toolbox for studying cerebrospinal fluid

van Gool, A. J., & Hendrickson, R. C. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.6 · Cited by 24 · see citing works

Interrelations between CSF Soluble AβPPβ, Amyloid-β 1-42, SORL1, and Tau Levels in Alzheimer's Disease

Alexopoulos, P., Guo, L., Tsolakidou, A. F., Kratzer, M., Grimmer, T., Westerteicher, C., Jiang, M., Bujo, H., Diehl‐Schmid, J., Kurz, A., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110983 · Cited by 23 · see citing works

CSF in Alzheimer's Disease

Zetterberg, H., Lautner, R., Skillbäck, T. B., Rosén, C., Shahim, P., Mattsson, N., & Blennow, K. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800141-7.00005-x · Cited by 21 · see citing works

Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis

LoPresti, P. (2022) · Biomedicines · doi:10.3390/biomedicines10051077 · Cited by 21 · see citing works

Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain

Mattsson, N., Johansson, P., Hansson, O., Wallin, A., Johansson, J.-O., Andréasson, U., Andersen, O., Haghighi, S., Olsson, M., Stridsberg, M., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091651 · Cited by 20 · see citing works

N-truncation and pyroglutaminylation enhances the opsonizing capacity of Aβ-peptides and facilitates phagocytosis by macrophages and microglia

Condic, M., Oberstein, T. J., i, M. H., Reimann, M. C., Kornhuber, J., Maler, J. M., & Spitzer, P. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.003 · Cited by 19 · see citing works

A Proteomic Approach for the Diagnosis of Bacterial Meningitis

Jesse, S., Steinacker, P., Lehnert, S., Sdzuj, M., Cepek, L., Tumani, H., Jahn, O., Schmidt, H., & Otto, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010079 · Cited by 19 · see citing works

Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome

Mai, W.-H., Hu, X.-Q., Lu, Z.-H., Peng, F.-H., & Wang, Y.-G. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900641 · Cited by 17 · see citing works

Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

Giacomucci, G., Mazzeo, S., Bagnoli, S., Casini, M., Padiglioni, S., Polito, C., Berti, V., Balestrini, J., Ferrari, C., Lombardi, G., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010047 · Cited by 16 · see citing works

Cerebrospinal fluid in the dementias

Zetterberg, H., Rohrer, J. D., & Schott, J. M. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00006-x · Cited by 12 · see citing works

Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis

Pietroboni, A. M., Colombi, A., Carandini, T., Contarino, V. E., Ghezzi, L., Fumagalli, G., Arighi, A., Fenoglio, C., Riz, M. A. D., Triulzi, F. M., et al. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101899 · Cited by 7 · see citing works

CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis

Pietroboni, A. M., di Cola, F. S., Colombi, A., Carandini, T., Fenoglio, C., Ghezzi, L., Riz, M. A. D., Triulzi, F. M., Scarpini, E. A., Padovani, A., et al. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101462 · Cited by 7 · see citing works

BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis

Bruno, A., Dolcetti, E., Azzolini, F., Buttari, F., Gilio, L., Iezzi, E., Galifi, G., Borrelli, A., Furlan, R., Finardi, A., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104528 · Cited by 5 · see citing works

Clinical Use of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

Zetterberg, H., Lunn, M. P., & Herukka, S. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.47 · Cited by 5 · see citing works

Structural and Metabolic Biomarkers in Multiple Sclerosis

Behroozi, Z., Atefimanesh, P., & Karimzadeh, F. (2018) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.6.2.94 · Cited by 4 · see citing works

The Serum Amyloid β Level in Multiple Sclerosis: A Case- Control Study

Etemadifar, M., Ghadimi, M., Ghadimi, K., & Alsahebfosoul, F. (2017) · Caspian Journal of Neurological Sciences · doi:10.29252/nirp.cjns.3.11.214 · Cited by 13 · see citing works

Potential Pathological Biomarkers in Multiple SclerosisPreprint

Mathur, D., Rout, S., Mishra, B., Rodas, G., Vallamkondu, J., Kandimalla, R., & Casanova, B. (2020) · Preprints.org · doi:10.20944/preprints202009.0293.v1 · Cited by 1 · see citing works

Molecular biomarkers and cognitive impairment in multiple sclerosis: A review

Esmaeili, S., Obeidat, A. Z., & Zabeti, A. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100077 · Cited by 3 · see citing works

Introduction: The Cardinal Role of Biobanks and Human Biospecimen Collections in Biomarker Validation: Issues Impeding Impact of Biomarker Research Outcomes

Puchois, P., Miranda, L. B., & van Gool, A. J. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734363-00073 · Cited by 3 · see citing works

Expression analysis of β-secretase (BACE1) and its naturally occurring anti-sense (BACE1-AS) in multiple sclerosis

Ganji, M., Dastmalchi, R., Sayad, A., Omrani, M. D., Mazdeh, M., Taheri, M. N., & Ghafouri‐Fard, S. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.10.009 · Cited by 1 · see citing works

CSF Biomarkers

Piccini, A. (2010) · The Open Nuclear Medicine Journal · doi:10.2174/1876388x01002010025 · Cited by 1 · see citing works

Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

Carandini, T. (2018) · doi:10.26226/morressier.5b75785e5aff7400151f39ed · Cited by 1 · see citing works

Establishment and Applications of a Multiple Sclerosis Biobank Analysis of Biomarkers and Therapeutic Complications in MS

Iacobaeus, E. (2010) · Figshare

Cerebrospinal fluid biomarkers for differentiating between Alzheimer’s disease and Vascular dementia

Bjerke, M. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Cerebrospinal Fluid Biomarkers to Monitor Treatment Effects in Alzheimer’s Disease and Related Conditions

Mattsson, N., Portelius, E., Blennow, K., & Zetterberg, H. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.75

BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis

Bruno, A., Dolcetti, E., Azzolini, F., Buttari, F., Gilio, L., Iezzi, E., Galifi, G., Borrelli, A., Furlan, R., Finardi, A., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104528 · Cited by 5 · see citing works

O3‐02–06: Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer's disease

Zetterberg, H., Andréasson, U., Hansson, O., Wu, G., Sankaranarayanan, S., Andersson, M. E., Buchhave, P., Londos, E., Umek, R. M., Minthon, L., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.419

Expression analysis of β-secretase (BACE1) and its naturally occurring anti-sense (BACE1-AS) in multiple sclerosis

Ganji, M., Dastmalchi, R., Sayad, A., Omrani, M. D., Mazdeh, M., Taheri, M. N., & Ghafouri‐Fard, S. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.10.009 · Cited by 1 · see citing works

β‐Site amyloid precursor protein–cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin‐related receptor with A‐type repeats, soluble amyloid precursor protein, and tau

Tsolakidou, A. F., Alexopoulos, P., Guo, L., Grimmer, T., Westerteicher, C., Kratzer, M., Jiang, M., Bujo, H., Roselli, F., Leante, M. R., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.015 · Cited by 19 · see citing works

Increased cathepsin B activity in multiple sclerosis brain

Bever, C. T., & Garver, D. W. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00039-5 · Cited by 71 · see citing works